Carregant...

Antibody neutralization of retargeted measles viruses

The measles virus (MV) vaccine lineage is a promising oncolytic but prior exposure to the measles vaccine or wild-type MV strains limits treatment utility due to the presence of anti-measles antibodies. MV entry can be redirected by displaying a polypeptide ligand on the Hemagglutinin (H) C-terminus...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lech, Patrycja J., Pappoe, Roland, Nakamura, Takafumi, Tobin, Gregory J., Nara, Peter L., Russell, Stephen J.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4123749/
https://ncbi.nlm.nih.gov/pubmed/24725950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2014.01.027
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!